The Use of a Triple-Emitter, UV-C Energy Disinfection System to Reduce CAUTI and CLABSI Rates
According to the CDC, roughly one in every 25 hospitalized patients has at least one healthcare-associated infection (HAI).1 HAIs create significant health risks and cost the healthcare industry billions of dollars each year.
In 2014, Jersey Shore University Medical Center (JSUMC), which is a part of Hackensack Meridian Health, was experiencing an increase in Catheter-Associated Urinary Tract Infections (CAUTI) and Central Line-Associated Bloodstream Infections (CLABSI) in its Medical Intensive Care Unit (MICU).
In this Whitepaper, sponsored by Surfacide, find out what JSUMC introduced to the patient care environment that would impact the CAUTI and CLABSI rates.
Helios® by Surfacide is a revolutionary, patented triple emitter UV-C hard surface disinfection system. Designed to precisely target all areas even those hidden by shadows the Helios systems advanced laser mapping technology scans a room, creates a plan, and gets to work. Environments are safely disinfected and ready for use in just one efficient cycle.
Tracking Pathogen Contamination in a New Children’s Outpatient Pulmonary Clinic
June 17th 2024A study at the 2024 APIC conference observed MRSA and Pseudomonas contamination in a new children's outpatient pulmonary clinic during construction and after patient use, highlighting significant infection risks.
Point of care high-level disinfection for ultrasound probes
May 22nd 2023As automated reprocessing solutions replace time-consuming manual processes, point of care HLD of ultrasound probes has become a safe and effective alternative to centralized methods. When taking into account key considerations around technology, traceability, safety and workflows, point of care HLD can be an efficient and cost-effective way to prevent patients from the risk of infection.
